# FDA recall D-0232-2022

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2021-10-27.

## Product

Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90

## Reason for recall

Labelling: Incorrect Exp. Date

## Distribution

Distributed Nationwide in the USA

## Key facts

- **Recall number:** D-0232-2022
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-10-27
- **Report date:** 2021-11-24
- **Termination date:** 2022-12-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0232-2022

## Citation

> AI Analytics. FDA recall D-0232-2022. Retrieved 2026-06-04 from https://api.ai-analytics.org/recall/D-0232-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*